If ready-to-use medicinal products are manufactured in a State with which Switzerland has not signed an agreement on the mutual recognition of the GMP control procedures and there are justified doubts about the safety or quality of the batches to be imported, Swissmedic may order that each batch undergo reanalysis in Switzerland.
Art. 14 – Reanalysis
Compare quotas
Art. 14
Reanalysis
- Language
- English (en)
- Data status
- 2025-03-15
Available language versions
The official sources and versions published by the competent authorities remain authoritative.
Rating categories
Enactment navigation
Loading the complete structure
The requested content is already available. Articles, annexes and all other structure nodes are now being added.
The official sources and versions published by the competent authorities remain authoritative.
rechtundgesetz.ch provides orientation and search in publicly accessible legal information, but no legal advice.
Read SR content
Read SR content
Compare quotas
Der Inhalt ist derzeit nicht darstellbar.
- Legal act context
- Structure path
As of
–
Latest RUG snapshot
–
Article version
Massgebend bleiben die offiziellen Quellen und Fassungen der zuständigen Behörden.
Rating categories
Art. 14 Reanalysis If ready-to-use medicinal products are manufactured in a State with which Switzerland has not signed an agreement on the mutual recognition of the GMP control procedures and there are justified doubts about the safety or quality of the batches to be imported, Swissmedic may order
- SR-Nummer
- SR 812.212.1
- Document type
- Ordinance
- Language
- English (en)
- Document date
- 2018-11-14
- Source
- Fedlex
- Legal area
- National law